Users online: 2087    [ij] [ij] [ij] 
Email id

Year : 2021, Volume : 14, Issue : 2
First page : ( 715) Last page : ( 724)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2021.00125.6

Development of nifedipine orodispersible tablets by different techniques using natural and synthetic superdisintegrants

Singh Kuljit1*, Sharma Shailesh2

1Resarch Scholar, IKG Punjab Technical University, Jalandhar-Kapurthala Highway, Kapurthala, Punjab. India, 144 603

2Pharmaceutical Research Division, Department of Pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, BELA (Ropar), Punjab, India, 140 111

*Corresponding Author E-mail: kuljitsaini85@gmail.com

Online published on 30 April, 2021.


The oral delivery of drugs undergoing extensive first-pass metabolism is a tedious task, as the bioavailability of such agents is severely hampered, resulting in poor pharmacological response and compromised dose economics. Cardiovascular diseases are a leading cause of mortality and morbidity all over the globe, wherein nifedipine is such a prescribed drug with extensive first-pass metabolism and compromised bioavailability. In an attempt to alleviate the concerns of nifedipine employing simple materials and methods, orodispersible tablets (ODTs) of nifedipine were explored using various methods and materials. Out of various methods viz. lyophilization technique, wet granulation, dry granulation and cotton-candy process, the last method fetched with ODTs with acceptable disintegration time, wetting time and drug release profile over 10 minutes in Sorenson's buffer simulating saliva. The novel material used Calcium Cross-Linked Cassia Fistula gum offered substantially improved ODT product over the conventional material, i.e., Croscarmellose Sodium (CCS). The optimized ODT not only improved the bioavailability of the drug by decreasing the drug extraction at the liver site, as evident from in-vivo pharmacokinetic studies, but also offered substantial reduction in the systolic blood pressure in L-NAME antihypertensive studies in Wistar rats. The in-vivo performance of the selected ODT was far more improved than that the available marketed product as well as the plain drug, advocating the superiority of the developed system over the marketed one. The pharmacokinetic, biodistribution and pharmacological evidences coupled with the results from the in-vitro parameters like wetting time, disintegration time and drug release profile provide a ray of hope for a commercially viable ODT product for nifedipine to manage the hypertension related problems.



Hypertension, Oral Disintegrating Tablets, Calcium Cross-Linked Cassia Fistula Gum, Cotton Candy Process, First-pass Metabolism.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
625,891,615 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.